Fig. 3From: Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastomaStem cell marker expression according to IDH-1/2 mutation status. In recurrent tumors, expression of CD133 and Nestin is significantly increased for IDH-1/2 wild-type gliomas. The relative number of positively stained glioma cells is shown for CD133 and Nestin as boxplot diagramsBack to article page